US Broker Ratings

Sanara MedTech Inc. (SMTI) Stock Analysis: A Healthcare Innovator with 77% Potential Upside

Sanara MedTech Inc. (SMTI) offers an intriguing opportunity for investors keen on the healthcare sector, where innovation and growth potential often intersect. Based in Fort Worth,..

Palvella Therapeutics, Inc. (PVLA)

⚠️ No article content returned.

..

Checkpoint Therapeutics, Inc. (CKPT) Stock Analysis: Is the 4.46% Upside Worth the Risk?

Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) is an intriguing player in the field of biotechnology, specializing in the development of innovative treatments for solid tumor cancers. With..

Cartesian Therapeutics, Inc. (RNAC) Investor Outlook: A Potential 261.67% Upside in the Biotech Sector

Cartesian Therapeutics, Inc. (RNAC), a promising player in the biotechnology sector, is capturing investor attention with its potential for a remarkable 261.67% upside. This clinical-stage company,..

Vanda Pharmaceuticals Inc. (VNDA): Investor Outlook Reveals 179.62% Potential Upside Amidst Challenging Financials

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA), a biotechnology company specializing in therapies for unmet medical needs, presents a mixed bag of opportunities and challenges for investors. With..

Gossamer Bio, Inc. (GOSS) Stock Analysis: A Look at the 489% Potential Upside in Biotechnology

Gossamer Bio, Inc. (NASDAQ: GOSS), a clinical-stage biopharmaceutical company, has been making waves in the biotechnology sector with its promising developments in pulmonary arterial hypertension (PAH)..

Phathom Pharmaceuticals, Inc. (PHAT) Stock Analysis: Unveiling 82% Potential Upside Amid Biotech Breakthroughs

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) is drawing significant attention from investors as it navigates the complex landscape of biopharmaceutical innovation. With a robust focus on gastrointestinal..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: A Biotech Gem with 443% Potential Upside

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a San Diego-based biotechnology company, is making waves in the healthcare sector with its innovative approach to developing mRNA-based therapeutics...

National Research Corporation (NRC) Stock Analysis: Exploring the 72.69% Return on Equity in a Competitive Healthcare Sector

National Research Corporation (NASDAQ: NRC) stands out in the healthcare sector through its innovative approach to health information services. Headquartered in Lincoln, Nebraska, the company provides..

TruBridge, Inc. (TBRG) Stock Analysis: Exploring a 27% Upside Potential

TruBridge, Inc. (NASDAQ: TBRG) is making waves in the healthcare sector, with its impressive array of health information services that cater to community hospitals, clinics, and..

Mereo BioPharma Group plc (MREO) Stock Analysis: A Potential 162% Upside in the Biotech Sector

Mereo BioPharma Group plc (NASDAQ: MREO), a prominent player in the biotechnology sector, is capturing the attention of investors with its robust therapeutic pipeline and ambitious..

Spok Holdings, Inc. (SPOK) Stock Analysis: High Dividend Yield and Notable Upside Potential

Spok Holdings, Inc. (NASDAQ: SPOK), a prominent player in the healthcare communication solutions sector, offers a compelling investment opportunity with its high dividend yield and significant..

Olema Pharmaceuticals (OLMA) Stock Analysis: A Biotech with an Impressive 502.79% Potential Upside

For investors seeking opportunities in the dynamic biotech industry, Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) presents a compelling case. With a market capitalization of $280.53 million, this..

Senseonics Holdings, Inc. (SENS) Stock Analysis: Exploring a 206% Potential Upside in the Medical Devices Sector

For investors eyeing opportunities in the healthcare sector, Senseonics Holdings, Inc. (NYSEAMERICAN: SENS) presents an intriguing prospect, especially given its standout potential upside of 206.69%. This..

Abeona Therapeutics Inc. (ABEO) Investor Outlook: Exploring a Potential 232% Upside

Abeona Therapeutics Inc. (NASDAQ: ABEO) stands out in the biotechnology sector with its intriguing blend of innovative therapies and significant market potential. As a clinical-stage biopharmaceutical..

Benitec Biopharma Inc. (BNTC) Stock Analysis: A Biotechnology Bet with 72% Potential Upside

Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage biotechnology firm specializing in DNA-directed RNA interference-based therapeutics, is currently capturing investor attention, thanks to its robust analyst ratings..

CytomX Therapeutics, Inc. (CTMX) Stock Analysis: Exploring a Promising 160.66% Potential Upside

CytomX Therapeutics, Inc. (NASDAQ: CTMX) is making waves in the biotechnology sector, captivating investor attention with its cutting-edge approach to cancer treatment and potential for significant..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 169% Potential Upside in the Biotech Arena

Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a promising player in the biotechnology sector, is capturing the attention of investors with its compelling growth narrative and significant market..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: A Stable Contender in the Healthcare Sector with Modest Upside Potential

Healthcare Services Group, Inc. (NASDAQ: HCSG) has been a reliable name in the healthcare services industry, providing indispensable management and operational services to nursing homes, retirement..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Unveiling a 197% Potential Upside in the Biotech Sector

Wave Life Sciences Ltd. (NASDAQ: WVE), a Singapore-based clinical-stage biotechnology company, is capturing attention in the healthcare sector with an impressive potential upside of 197.59%. As..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds